A recent study published in Nature Communications by researchers at the National Institute of Allergy and Infectious Diseases (NIAID) and collaborators evaluated a replicating RNA (repRNA) vaccine ...

That means that an RNA virus such as H5N1 is particularly good at evolving to infect new species. But influenza viruses have another tool that makes them still more dangerous: an ability to swap ...

As the H5N1 bird flu virus steamrolls its way across ... introducing genetic mutations into its RNA to see what changes could transform it from a virus that passed easily between birds into ...

Researchers uncover how a key human immune protein curbs H5N1 avian flu, but the virus is evolving—could we be on the brink of a new zoonotic threat? Research Letter: Replication Restriction of ...

Its alert to doctors and hospitals follows a few rare but mysterious bird flu cases in the US – including, most recently, a child in San Francisco confirmed to have had H5N1 influenza – that ...

RNA polymerase is an enzyme that is responsible for copying a DNA sequence into an RNA sequence, duyring the process of transcription. As complex molecule composed of protein subunits, RNA ...

SAN DIEGO, January 10, 2025--(BUSINESS WIRE)--Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development ...

STP702 has been shown to be effective against H5N1 (avian flu ... dsRNA: Double-stranded RNA; pre-miRNA: Precursor miRNA; pri-miRNA: Primary miRNA; RISC: RNA-induced silencing complex; UTR ...

Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a commercial messenger RNA medicines company ... also known as LUNAR-H5N1, for active immunization to prevent ...